{"id":194082,"url":"https://lda.senate.gov/api/v1/clients/194082/?format=json","client_id":48,"name":"THE LIVINGSTON GROUP FOR TITAN PHARMACEUTICALS","general_description":"Pharmaceutical, makes and markets Probuphine, an implant to treat opioid addiction.","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-12-03","registrant":{"id":400678024,"url":"https://lda.senate.gov/api/v1/registrants/400678024/?format=json","house_registrant_id":null,"name":"CHATMAN, LLC","description":"consulting firm","address_1":"13601 Belle Chasse Blvd","address_2":"Suite 316","address_3":null,"address_4":null,"city":"Laurel","state":"MD","state_display":"Maryland","zip":"20707","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PRISCILLA CHATMAN","contact_telephone":"+1 202-309-2777","dt_updated":"2022-04-06T16:07:54.918677-04:00"}}